A comparison of peripheral blood stem cell collection outcomes for multiple myeloma; mobilization matters in the era of IMiD induction
Abstract Collection of peripheral blood stem cells (PBSCs) for autologous stem cell transplant (ASCT) requires mobilization from the bone marrow. There is variation in mobilization choice; during the COVID‐19 pandemic BSBMT&CT guidelines recommended using granulocyte‐colony stimulating factor (G...
Main Authors: | Thea Chandler, Christopher Parrish, Marina Karakantza, Jonathan Carmichael, David Pawson, Gordon Cook, Frances Seymour |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | eJHaem |
Subjects: | |
Online Access: | https://doi.org/10.1002/jha2.702 |
Similar Items
-
IMiD-Free Interval and IMiDs Sequence: Which Strategy Is Better Suited for Lenalidomide-Refractory Myeloma?
by: Kazuhito Suzuki, et al.
Published: (2023-11-01) -
Outcomes of poor peripheral blood stem cell mobilizers with multiple myeloma at the first mobilization: A multicenter retrospective study in Japan
by: Yurie Miyamoto‐Nagai, et al.
Published: (2022-08-01) -
Hematopoietic stem cell transplantation in the treatment of multiple myeloma
by: Angelo Maiolino
Published: (2002-01-01) -
Stem Cell Mobilization with Ixazomib and G-CSF in Patients with Multiple Myeloma
by: Selina Bühler, et al.
Published: (2023-01-01) -
Generation of Induced Pluripotent Stem Cells from Patients with Multiple Myeloma
by: İrem Yılmaz Başaran, et al.
Published: (2021-12-01)